BRPI0603774A - composições, métodos e kits para tratar dermatites alérgicas da pele - Google Patents

composições, métodos e kits para tratar dermatites alérgicas da pele

Info

Publication number
BRPI0603774A
BRPI0603774A BRPI0603774-7A BRPI0603774A BRPI0603774A BR PI0603774 A BRPI0603774 A BR PI0603774A BR PI0603774 A BRPI0603774 A BR PI0603774A BR PI0603774 A BRPI0603774 A BR PI0603774A
Authority
BR
Brazil
Prior art keywords
compositions
methods
kits
treating allergic
dermatitis
Prior art date
Application number
BRPI0603774-7A
Other languages
English (en)
Inventor
Laura Magee
Original Assignee
Johnson & Johnson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson filed Critical Johnson & Johnson
Publication of BRPI0603774A publication Critical patent/BRPI0603774A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/45—Derivatives containing from 2 to 10 oxyalkylene groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Toxicology (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Detergent Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

COMPOSIçõES, MéTODOS E KITS PARA TRATAR DERMATITES ALéRGICAS DA PELE. A invenção inclui composições adequadas para remoção de urushiol da pele que foi exposta a ele, cujas composições contêm um etoxilato e sódio lauril sarcosinato, métodos para tratar dermatite alérgica da pele que foi exposta ao urushiol, e kits adequados para tratamento de dermatite alérgica.
BRPI0603774-7A 2005-09-09 2006-09-08 composições, métodos e kits para tratar dermatites alérgicas da pele BRPI0603774A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US71564705P 2005-09-09 2005-09-09
US11/464,986 US20070059268A1 (en) 2005-09-09 2006-08-16 Compositions, methods and kits for treating allergic dermatitis of skin

Publications (1)

Publication Number Publication Date
BRPI0603774A true BRPI0603774A (pt) 2007-05-02

Family

ID=37654805

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0603774-7A BRPI0603774A (pt) 2005-09-09 2006-09-08 composições, métodos e kits para tratar dermatites alérgicas da pele

Country Status (7)

Country Link
US (1) US20070059268A1 (pt)
EP (1) EP1762227B1 (pt)
JP (1) JP2007084538A (pt)
AU (1) AU2006208422A1 (pt)
BR (1) BRPI0603774A (pt)
CA (1) CA2559279A1 (pt)
DE (1) DE602006006950D1 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070059679A1 (en) * 2005-09-09 2007-03-15 Michelle Garay Method for demonstrating efficacy of a topically applied active ingredient
US7906149B2 (en) 2007-05-25 2011-03-15 Boval Company, L.P. Method for treating allergic dermatitis
WO2009048681A2 (en) * 2007-08-06 2009-04-16 The Regents Of The University Of California Methods of tissue-based diagnosis
US9814422B2 (en) 2007-08-06 2017-11-14 The Regents Of The University Of California Compositions for solubilizing cells and/or tissue
FR2920309B1 (fr) * 2007-08-28 2010-05-28 Galderma Res & Dev Utilisation de travoprost pour traiter la chute des cheveux
EP2396654B1 (en) 2009-02-13 2016-02-10 The Regents of The University of California Composition and method for tissue-based diagnosis
EP3046629A4 (en) * 2013-09-20 2017-07-12 Children's Medical Center Corporation Treatment of inflammatory skin disease
US11154486B2 (en) * 2020-02-14 2021-10-26 William M. Yarbrough Foundation Detergent compositions for washing urushiol and methods of treating urushiol induced contact dermatitis
US11191708B2 (en) * 2020-02-17 2021-12-07 William M. Yarbrough Foundation Sodium lauroyl sarcosinate containing detergent compositions

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4431743A (en) * 1978-03-16 1984-02-14 Cornell Research Foundation, Inc. Method for determining steroids in human body liquids
US4178373A (en) * 1978-08-21 1979-12-11 William H. Rorer, Inc. Coal tar gel composition
US4960467A (en) * 1985-02-11 1990-10-02 The United States Of America As Represented By The Secretary Of The Army Dermal substance collection device
FR2700010B1 (fr) * 1992-12-24 1995-03-17 Rocher Yves Biolog Vegetale Méthode et dispositif pour tester la réactivité de cellules à l'égard de produits.
CN1262615A (zh) * 1997-06-04 2000-08-09 普罗克特和甘保尔公司 含酸性表面活性剂的、温和漂去型抗微生物液体清洁组合物
WO1999067645A1 (en) * 1998-06-24 1999-12-29 Transderm Diagnostics, Inc. Non-invasive transdermal detection of analytes
US6949338B2 (en) * 1998-08-18 2005-09-27 Dermtech International Methods and kits for obtaining and analyzing skin samples for the detection of nucleic acids
US6495498B2 (en) * 1999-05-27 2002-12-17 Johnson & Johnson Consumer Companies, Inc. Detergent compositions with enhanced depositing, conditioning and softness capabilities
US6762158B2 (en) * 1999-07-01 2004-07-13 Johnson & Johnson Consumer Companies, Inc. Personal care compositions comprising liquid ester mixtures
US6423746B1 (en) * 1999-07-03 2002-07-23 The William M. Yarbrough Foundation Urushiol induced contact dermatitis and method of use
US7008963B2 (en) * 1999-07-03 2006-03-07 The William M. Yarbrough Foundation Urushiol induced contact dermatitis solution
US6607735B2 (en) * 2000-12-21 2003-08-19 Johnson & Johnson Consumer Companies, Inc. Method for reducing the appearance of dark circles under the eyes
DE60220145T2 (de) * 2001-03-16 2008-02-14 Johnson & Johnson Consumer Companies, Inc. Verwendung eines mutterkrautextrakts zur regulierung der hautalterung
US20030068663A1 (en) * 2001-09-06 2003-04-10 Kelly Huang Method and kit for measuring skin inflammation or irritation
US6803056B2 (en) * 2001-09-14 2004-10-12 Terence M. Dolak Method and composition for treating viral outbreaks
ES2375357T3 (es) * 2002-05-02 2012-02-29 E-L Management Corp. Procedimiento de mejora de la actividad biológica de extractos de origen vegetal.
DE10254872A1 (de) * 2002-11-25 2004-06-03 Symrise Gmbh & Co. Kg Anthranilsäureamide und deren Derivate als kosmetische und pharmazeutische Wirkstoffe
US6812832B2 (en) * 2002-11-26 2004-11-02 General Motors Corporation Vehicle communication system with integrated pre-impact sensing
WO2004052358A1 (en) * 2002-12-04 2004-06-24 The William Yarbrough Foundation Urushiol induced contact dermatitis treatment and method of use
US20050100621A1 (en) * 2003-11-07 2005-05-12 Popp Karl F. Dermatological compositions
US20070059390A1 (en) * 2005-09-09 2007-03-15 Laura Magee Compositions for inhibiting or reducing inflammation of skin
US20070059679A1 (en) * 2005-09-09 2007-03-15 Michelle Garay Method for demonstrating efficacy of a topically applied active ingredient

Also Published As

Publication number Publication date
EP1762227A3 (en) 2007-03-21
JP2007084538A (ja) 2007-04-05
EP1762227B1 (en) 2009-05-27
AU2006208422A1 (en) 2007-03-29
DE602006006950D1 (de) 2009-07-09
US20070059268A1 (en) 2007-03-15
CA2559279A1 (en) 2007-03-09
EP1762227A2 (en) 2007-03-14

Similar Documents

Publication Publication Date Title
BR112021006392A2 (pt) moduladores da alfa-1 antitripsina
WO2007092622A3 (en) Compositions and methods for treating bone
CO2021004141A2 (es) Moduladores de la expresión de pnpla3
CR11731A (es) Composiciones y procedimientos para su preparación y uso
MA45747A (fr) Génération de cellules bêta fonctionnelles à partir de progéniteurs endocrines dérivés de cellules souhes pluripotentes humaines
CO6210786A2 (es) Implemento de cuidado oral que alberga un agente de cuidado oral
MX379016B (es) Composiciones y metodos para tratar enfermedad de gaucher.
BRPI0809164B8 (pt) Composição para administração tópica e composição farmacêutica compreendendo a referida composição
ECSP20082339A (es) Moduladores de la expresión de apol1
CO2023006684A2 (es) Anticuerpos contra sars-cov-2 y usos de los mismos
NO20091544L (no) Sammensetninger av CHK1 inhibitorer
BRPI0520539A2 (pt) composições minimizadoras de cachos queratina protetora, método e kit para tal
EA200970175A1 (ru) Способы и композиции для ингибирования ангиогенеза
MX2017016024A (es) Composiciones de nicotinamida ribósido y pteroestilbeno y métodos para el tratamiento de trastornos de la piel.
BRPI0712607A8 (pt) métodos de tratamento de acidente vascular cerebral
CL2013003307A1 (es) Agente que comprende ciazofamida o fenamidona; y su uso para tratar micosis en peces e invertebrados en todos sus estadios de desarrollo causada por hongos de los generos saprolegnia, achlya y aphanomyces (div.sol.n°1056-08).
CO2019011265A2 (es) Moduladores de la expresión de pcsk9
UY30220A1 (es) Compuestos de tetrahidropiridotienopirimidina y metodos para su empleo
BR112016024440A2 (pt) composições para tratamento bucal
MX2020009147A (es) Moduladores de la expresion de irf4.
AR077372A1 (es) Composiciones y metodos para tratar infecciones oftalmicas oticas o nasales
CA2898515C (en) Methods for depyrogentating a seaweed extract
BRPI0603774A (pt) composições, métodos e kits para tratar dermatites alérgicas da pele
EP4341382A4 (en) COMPOSITIONS AND METHODS FOR TREATING DISEASES
BRPI0603772A (pt) composições para a inibição ou redução de inflamação da pele

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B11E Dismissal acc. art. 34 of ipl - requirements for examination incomplete
B11T Dismissal of application maintained [chapter 11.20 patent gazette]